These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9923535)

  • 41. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study.
    Dazzi C; Cariello A; Rosti G; Tienghi A; Molino A; Sabbatini R; Aieta M; Frassineti GL; Vertogen B; Giovanis P; Marangolo M
    Haematologica; 2001 May; 86(5):523-9. PubMed ID: 11410417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
    Kröger N; Frick M; Gluz O; Mohrmann S; Metzner B; Jackisch C; Ko Y; Lindemann HW; Meier CR; Lohrmann HP; Ruffert U; Hänel M; Bodenstein H; Neubauer A; Ehninger G; Wolf HH; Kolbe K; Burock K; Zander AR; Nitz U
    J Clin Oncol; 2006 Aug; 24(24):3919-26. PubMed ID: 16921043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
    Holland HK; Dix SP; Geller RB; Devine SM; Heffner LT; Connaghan DG; Hillyer CD; Hughes LL; Miller RL; Moore MR; Winton EF; Wingard JR
    J Clin Oncol; 1996 Apr; 14(4):1156-64. PubMed ID: 8648370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of epirubicin in advanced breast cancer.
    Conte PF; Gennari A; Landucci E; Orlandini C
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S46-51. PubMed ID: 11970749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
    Vredenburgh JJ; Coniglio D; Broadwater G; Jones RB; Ross M; Shpall EJ; Hussein A; Rizzieri D; Marks LB; Gilbert C; Affronti ML; Moore S; McDonald C; Petros WP; Peters WP
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):195-203. PubMed ID: 16443517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
    Del Mastro L; Venturini M; Viscoli C; Bergaglio M; Signorini A; Bighin C; Bertelli G; Semino C; Pietra G; Bertoglio S; Sertoli MR; Lambiase A; Rosso R; Melioli G
    Ann Oncol; 2001 Apr; 12(4):505-8. PubMed ID: 11398884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer.
    Levi JA; Beith JM; Snyder RD; Tattersall MH; Bell D; Wheeler H
    Aust N Z J Med; 1995 Oct; 25(5):474-8. PubMed ID: 8588767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).
    Bengala C; Pazzagli I; Innocenti F; Donati S; Favre C; Menconi MC; Greco F; Danesi R; Orlandini C; Guarneri V; Del Tacca M; Conte PF
    Ann Oncol; 2001 Jan; 12(1):69-74. PubMed ID: 11249051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
    Ayash LJ; Wheeler C; Fairclough D; Schwartz G; Reich E; Warren D; Schnipper L; Antman K; Frei E; Elias A
    J Clin Oncol; 1995 Aug; 13(8):2043-9. PubMed ID: 7636547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin.
    Lück HJ; Thomssen C; Du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):36-9. PubMed ID: 9516602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
    Hamilton BK; Rybicki L; Abounader D; Andresen S; Kalaycio M; Sobecks R; Pohlman B; Hanna R; Dean R; Liu H; Hill B; Bolwell B; Copelan E
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):115-24. PubMed ID: 26183670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer.
    Hansen F; Møller P; Skovsgaard T
    Cancer Chemother Pharmacol; 1996; 37(4):377-81. PubMed ID: 8548885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
    Cagnoni PJ; Nieto Y; Shpall EJ; Bearman SI; Barón AE; Ross M; Matthes S; Dunbar SE; Jones RB
    J Clin Oncol; 1998 May; 16(5):1661-8. PubMed ID: 9586876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
    Steenbruggen TG; Steggink LC; Seynaeve CM; van der Hoeven JJM; Hooning MJ; Jager A; Konings IR; Kroep JR; Smit WM; Tjan-Heijnen VCG; van der Wall E; Bins AD; Linn SC; Schaapveld M; Jacobse JN; van Leeuwen FE; Schröder CP; van Tinteren H; de Vries EGE; Sonke GS; Gietema JA
    JAMA Oncol; 2020 Apr; 6(4):528-534. PubMed ID: 31999296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
    Cao TM; Negrin RS; Stockerl-Goldstein KE; Johnston LJ; Shizuru JA; Taylor TL; Rizk NW; Wong RM; Blume KG; Hu WW
    Biol Blood Marrow Transplant; 2000; 6(4):387-94. PubMed ID: 10917574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
    Bhalla KS; Wilczynski SW; Abushamaa AM; Petros WP; McDonald CS; Loftis JS; Chao NJ; Vredenburgh JJ; Folz RJ
    Am J Respir Crit Care Med; 2000 Jan; 161(1):17-25. PubMed ID: 10619792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
    Eder JP; Antman K; Peters W; Henner WD; Elias A; Shea T; Schryber S; Andersen J; Come S; Schnipper L
    J Clin Oncol; 1986 Nov; 4(11):1592-7. PubMed ID: 3534155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation.
    Ghalie R; Richman CM; Adler SS; Cobleigh MA; Korenblit AD; Manson SD; McLeod BC; Taylor SG; Valentino LA; Wolter J
    J Clin Oncol; 1994 Feb; 12(2):342-6. PubMed ID: 8113841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.